News
The newly approved medication, Coartem Baby, is a combination of two antimalarials. It is a lower dose version of a tablet ...
A new study shows that the health of U.S. children has deteriorated over the past 17 years, with kids today more likely to ...
Sunscreen is not one size fits all, and Maryland dermatologist Dr. Kate Viola has recommendations that fit all age groups ...
The Nigerian Institute of Medical Research (NIMR) has raised the alarm that Nigeria tops the infant and maternal mortality table in the world, decrying lack of viable data on the health menace. Faced ...
The study, known as Safety and Antimicrobial Resistance of Mass Administration of Azithromycin Among Children (SARMAAN), was initiated in line with the World Health Organization’s 2022 guidelines.
The Kaduna State Government says it has concluded plans to administer Azithromycin (antimicrobial resistance drug) on 2.8 million children in the state. The State Deputy Governor, Hadiza Balarabe ...
Kaduna govt targets 2.8m children for Azithromycin administration Ms Balarabe said the mass administration of Azithromycin is for children between ages one to 59 months by Agency Report May 26, 2025 ...
“Azithromycin did not decrease the severity of wheezing illnesses in these children, even if they were positive for bacteria that are considered usually pathogenic in this age group,” Fernando ...
The aim of the project was mainly to ensure that children between 1-11 months in the LGA where we piloted it, will receive Azithromycin and along side, we will be monitoring the safety of the ...
No fewer than 36,000 children have received Azithromycin treatment under the pilot phase of the SARMAAN Project aimed at improving child survival rates in Ikono Local Government Area of Akwa Ibom ...
As part of its strategy, the project also engaged caregivers to demonstrate the efficacy and benefits of the intervention. Speaking at the close-out ceremony of the pilot phase in Uyo, Project ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results